Cardiovascular
The circulatory system is a vast network of organs and vessels that is responsible for the flow of blood, nutrients, oxygen and other gases, and hormones to and from cells. The system consists of three independent systems that work together: the heart (cardiovascular), lungs (pulmonary), and arteries, veins, coronary and portal vessels (systemic). Together, the heart, blood, and blood vessels make up the cardiovascular component of the circulatory system. It includes the pulmonary circulation, a "loop" through the lungs where blood is oxygenated. It also incorporates the systemic circulation, which runs through the rest of the body to provide oxygenated blood.
Because of its vastness and critical nature, the circulatory system is one of the systems of the body most prone to disease. Disorders of this system are the leading cause of death among adults in the majority of countries world-wide, arteriosclerosis being one of the most common diseases. It is characterized by fatty deposits in the arteries that cause the walls to stiffen and thicken the walls, and may result in restricted blood flow and ischemia. This may result in symptoms such as angina and dyspnea, necrosis, and ultimately in heart attack or stroke. Hypertension, another circulatory is disease, causes the heart to work harder and can lead to complications as a heart attack, a stroke, or kidney failure. Abnormal blood lipid levels, that is high total cholesterol, high levels of triglycerides, high levels of low-density lipoprotein or low levels of high-density lipoprotein (HDL) cholesterol all increase the risk of heart disease and stroke, and are of particular interest of modern research. Besides changing food intake habits of patients suffering from cardiovascular diseases, in combination with the stimulation to increase physical exercise, special medication may also modify a patients blood lipid profile and prevent the person from developing life threatening circulatory diseases.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
1309 | (R)-(-)-BMS 204352 | Potassium channel opener; Less active enantiomer of Axon 1112 | €145.00 | |
1308 | (±)-BMS 204352 | Potassium channel opener; racemate of Axon 1112 | Inquire | |
1313 | 1-EBIO | K+ channel opener (Ca2+ activated) | €50.00 | |
2243 | AVE 0118 hydrochloride | Potassium channel blocker (Kv1.5 (IKur), Kv4.3 (Ito), Kir3.4 (IKAch), and IKr currents) | €120.00 | |
1112 | BMS 204352 | Maxi K+ channel opener | €120.00 | |
1294 | Chromanol 293B | KCNQ1 channel blocker | €120.00 | |
1322 | DMP 543 | K+ channel blocker; Ach release stimulator | €90.00 | |
2103 | Dofetilide | Kv11.1 (hERG) channel blocker | €85.00 | |
1437 | Flupirtine maleate | Analgesic | €65.00 | |
2064 | Glibenclamide potassium salt | KATP channel blocker; inhibits SUR1 | €50.00 | |
1757 | HMR 1098 | K+ channel blocker (SUR1/Kir6.2 selective) | €95.00 | |
2724 | ICA-069673 | KCNQ2/KCNQ3 channel opener; Anti-convulsant | €90.00 | |
3495 | Ivabradine hydrochloride | Selective sinus node I(f) channel inhibitor | €50.00 | |
3516 | KCa modulator RA-2 | Potent and selective KCa2/3 pan inhibitor | €110.00 | |
1735 | Kv1.3 Channel blocker 42 | Kv1.3 potassium channel blocker | €110.00 | |
4046 | Levosimendan | Calcium sensitiser | €60.00 | |
3032 | LUF7244 | Potent negative allosteric modulator (NAM) of the Kv11.1 (hERG) channel | €140.00 | |
3490 | Minoxidil | K+ channel opener (ATP sensitive, vascular) | €50.00 | |
2840 | ML 365 | Potent and selective inhibitor of the TASK-1 potassium channel | €135.00 | |
2615 | ML252 | Selective and brain penetrant KCNQ2 inhibitor | €95.00 | |
3196 | ML277 | Potent and selective KCNQ1 channel activator | €80.00 | |
1647 | NN 414 | K+ channel opener (SUR1/Kir6.2 selective) | €110.00 | |
2854 | NS 1619 | Selective activator of large-conductance Ca2+-activated potassium (BK) channels | €95.00 | |
2329 | NS 19504 | Potent activator of large-conductance Ca2+-activated potassium (BK) channels | €90.00 | |
2094 | NS 6180 | KCa3.1 channel blocker | €90.00 | |
1525 | Retigabine | KCNQ channel opener; Anti-convulsant | €90.00 | |
2252 | Retigabine dihydrochloride | KCNQ channel opener; Anti-convulsant | €90.00 | |
1657 | S 9947 | Ikur/Kv1.5 channel Inhibitor | €125.00 | |
3951 | Senicapoc | Potent and selective antagonist of the Gardos channel | €65.00 | |
3593 | VU0468554 | Selective cardiac GIRK inhibitor | €110.00 |